Peter Hollenhorst

  • 1607 Citations
  • 16 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Peter Hollenhorst is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 24 Similar Profiles
Transcription Factors Medicine & Life Sciences
Prostate Medicine & Life Sciences
Transcription Factor AP-1 Medicine & Life Sciences
Cell Movement Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Genes Medicine & Life Sciences
Gene Expression Medicine & Life Sciences
Genome Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 2000 2018

  • 1607 Citations
  • 16 h-Index
  • 26 Article
  • 1 Chapter

Common ELF1 deletion in prostate cancer bolsters oncogenic ets function, inhibits senescence and promotes docetaxel resistance

Budka, J. A., Ferris, M. W., Capone, M. J. & Hollenhorst, P., May 1 2018, In : Genes and Cancer. 9, 5-6, p. 198-214 17 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
2 Citations (Scopus)

Electrostatic repulsion causes anticooperative DNA binding between tumor suppressor ETS transcription factors and JUN–FOS at composite DNA sites

Madison, B. J., Clark, K. A., Bhachech, N., Hollenhorst, P., Graves, B. J. & Currie, S. L., Jan 1 2018, In : Journal of Biological Chemistry. 293, 48, p. 18624-18635 12 p.

Research output: Contribution to journalArticle

Static Electricity
Transcription Factors
13 Citations (Scopus)

ETS1 induction by the microenvironment promotes ovarian cancer metastasis through focal adhesion kinase

Tomar, S., Plotnik, J. P., Haley, J., Scantland, J., Dasari, S., Sheikh, Z., Emerson, R., Lenz, D., Hollenhorst, P. & Mitra, A., Feb 1 2018, In : Cancer Letters. 414, p. 190-204 15 p.

Research output: Contribution to journalArticle

Focal Adhesion Protein-Tyrosine Kinases
Ovarian Neoplasms
Neoplasm Metastasis
Transcription Factors
Cellular Microenvironment
8 Citations (Scopus)

Therapeutic targeting of TFE3/IRS-1/PI3K/mTOR axis in translocation renal cell carcinoma

Damayanti, N. P., Budka, J. A., Khella, H. W. Z., Ferris, M. W., Ku, S. Y., Kauffman, E., Wood, A. C., Ahmed, K., Chintala, V. N., Adelaiye-Ogala, R., Elbanna, M., Orillion, A., Chintala, S., Kao, C., Marston Linehan, W., Yousef, G. M., Hollenhorst, P. & Pili, R., Dec 1 2018, In : Clinical Cancer Research. 24, 23, p. 5977-5989 13 p.

Research output: Contribution to journalArticle

Phosphatidylinositol 3-Kinases
Renal Cell Carcinoma
S 6
High-Throughput Nucleotide Sequencing
10 Citations (Scopus)

EZH2 modifies sunitinib resistance in renal cell carcinoma by kinome reprogramming

Adelaiye-Ogala, R., Budka, J., Damayanti, N. P., Arrington, J., Ferris, M., Hsu, C. C., Chintala, S., Orillion, A., Miles, K. M., Shen, L., Elbanna, M., Ciamporcero, E., Arisa, S., Pettazzoni, P., Draetta, G. F., Seshadri, M., Hancock, B., Radovich, M., Kota, J., Buck, M. & 9 others, Keilhack, H., McCarthy, B. P., Persohn, S. A., Territo, P., Zang, Y., Irudayaraj, J., Tao, W. A., Hollenhorst, P. & Pili, R., Dec 1 2017, In : Cancer Research. 77, 23, p. 6651-6666 16 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Receptor Protein-Tyrosine Kinases
Drug Resistance